retatrutide phase 3 results are in. TRIUMPH-1 topline: 28.3% average weight loss at 80 weeks, 30.3% at 104 weeks in participants with BMI 35 or higher. That averages 85 lbs. No pharmaceutical Phase III retatrutide study demonstrates
Pay in 4 interest-free payments of $5.46 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27










:max_bytes(150000):strip_icc()/VWH-Zepbound-a91ec7a305e8407d83daa7b41039b4aa.jpg)


















